<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00994708</url>
  </required_header>
  <id_info>
    <org_study_id>R04002M</org_study_id>
    <nct_id>NCT00994708</nct_id>
  </id_info>
  <brief_title>The Effect of Esomeprazole and Fundoplication on Airways</brief_title>
  <official_title>The Effect of Esomeprazole and Nissen Fundoplication on Bronchial Responsiveness, Quality of Life, Exhaled Nitric Oxide and Pulmonary Function in Patients With Gastroesophageal Reflux Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tampere University Hospital</source>
  <brief_summary>
    <textblock>
      Evaluate the prevalence of bronchial responsiveness (BHR) among patients with&#xD;
      gastroesophageal reflux disease (GERD).&#xD;
&#xD;
      Investigate correlation between bronchial reactivity and the severity of GERD, and similarly&#xD;
      investigate the correlation between exhaled nitric oxide (NO) and the severity of GERD.&#xD;
&#xD;
      Compare the effects of esomeprazole 40 mg twice daily and Nissen fundoplication on bronchial&#xD;
      reactivity, exhaled NO, pulmonary function and quality of life.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2004</start_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <condition>Airway Responsiveness</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>esomeprazole</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Over 18 of age&#xD;
&#xD;
          2. Diagnosis of gastroesophageal reflux disease&#xD;
&#xD;
          3. Compliance to perform methacholine inhalation challenge (judged by the investigator)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Known allergy to esomeprazole or any other PPI&#xD;
&#xD;
          2. Use of systemic corticosteroids within 3 weeks before any study visit&#xD;
&#xD;
          3. Pregnancy (in a written informed consent patients are asked to assure that they are&#xD;
             not pregnant and they are also told to immediately stop the study medication if they&#xD;
             become pregnant during the study)&#xD;
&#xD;
          4. Incapability to keep a 3-week washout with usual antireflux medication prior to the&#xD;
             first visit&#xD;
&#xD;
          5. Regular use of PPI or H2-RA medication 3 months after fundoplication&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <zip>33521</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <study_first_submitted>October 12, 2009</study_first_submitted>
  <study_first_submitted_qc>October 13, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 14, 2009</study_first_posted>
  <last_update_submitted>October 13, 2009</last_update_submitted>
  <last_update_submitted_qc>October 13, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 14, 2009</last_update_posted>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esomeprazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

